My
MyTrials.ai
Overview
MyTrials.ai is an AI-powered platform designed to connect patients with suitable clinical trials. The platform aims to simplify the process of finding and enrolling in clinical research for individuals and to streamline patient recruitment for researchers and trial sponsors.
- What it does: MyTrials.ai utilizes AI to match patients with clinical trials based on their medical condition, location, age, demographics, and health history. It pulls information from a central clinical trial database and filters trials based on eligibility criteria. The platform also supports the identification of healthy volunteers for trials.
- Who it is for: The tool is intended for patients seeking clinical trial opportunities, as well as for researchers, pharmaceutical sponsors, Contract Research Organizations (CROs), and trial sites involved in clinical trial recruitment and management. It can be used across various therapeutic areas.
- How it fits a clinical or practice workflow: For physicians and their practices, MyTrials.ai can serve as a resource to help patients identify potential clinical trial options. The platform aims to reduce the burden of manual trial searches for patients and their care teams. For researchers and CROs, it offers tools for intelligent patient screening, predictive enrollment analytics, and real-time matching algorithms to accelerate trial enrollment and manage recruitment.
- Notable capabilities: Key features include AI-driven patient-trial matching, automated pre-screening, digital patient outreach, and real-time dashboards with insights into referral volume, patient demographics, and engagement rates. The platform is designed to scale for multi-site and international trials, providing region-based matching and localized pre-screening. MyTrials.ai also provides information on Expanded Access Programs.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-powered patient matching and pre-screening
- Verified patient network across multiple therapeutic areas
- Human navigators for patient support and guidance
- Real-time dashboards with insights into referral volume, patient demographics, and engagement rates
- Customized clinical trial awareness campaigns
- Seamless integration of key stakeholders in the clinical trial ecosystem
- Automated pre-screening and digital patient outreach
- Compliance tracking and data quality monitoring
- Scalability for multi-site and international trials with region-based matching
- AI-driven translation tools for global accessibility
Use Cases
- Connecting patients with suitable clinical trials
- Accelerating clinical trial enrollment for researchers and CROs
- Optimizing patient recruitment strategies
- Enhancing patient engagement and retention in trials
- Streamlining clinical trial management across multiple sites and internationally
- Providing accessible information and support for patients navigating clinical trial options
What Physicians Need to Know
Clinical Trial Matching
MyTrials.ai specializes in AI-powered clinical trial matching, connecting patients with suitable trials based on their medical condition, location, age, demographics, and health history. The platform uses AI and clinical expertise to scan thousands of trials and highlight those most likely to fit a patient's situation.
AI-Powered Patient Recruitment
For researchers and CROs, MyTrials.ai accelerates trial enrollment by optimizing patient matching using advanced AI technology. It aims to reduce time-to-enrollment and enhance the efficiency of clinical trials.
Patient-Centric Approach
The platform is designed to be patient-first, offering personalized trial matching and simplifying complex medical information. It provides a free resource hub for patients and families to understand how clinical trials work.
Global Trial Access
MyTrials.ai facilitates access to international trials by using AI to identify eligible patients worldwide, helping to reduce recruitment timelines and improve study diversity. It also offers language and accessibility tools to help patients understand trial requirements across different countries.
Support for Expanded Access Programs
Beyond clinical trials, MyTrials.ai helps patients explore alternative pathways like Expanded Access Programs (EAPs) when they don't qualify for a trial or if there's no nearby trial site. The platform aims to bridge communication gaps between patients, physicians, and sponsors regarding EAPs.
Real-time Analytics and Compliance
The platform offers real-time dashboards with insights into referral volume, patient demographics, drop-off points, and engagement rates. It is built with data security and compliance in mind, adhering to standards like HIPAA, PIPEDA, and GDPR.
Collaboration Features
MyTrials.ai connects key stakeholders in the clinical trial ecosystem, including pharma sponsors, CROs, trial sites, EMR networks, and patient advocacy groups, to enhance collaboration and streamline the recruitment process.
Physician Tip
MyTrials.ai can be a valuable tool for physicians to help their patients find relevant clinical trials and understand expanded access options. The platform's AI-powered matching can quickly identify trials that fit a patient's unique health needs and circumstances, reducing the burden of manual searching. Physicians can also leverage the platform's resources to help patients understand complex medical information and prepare for discussions with trial sites. Additionally, MyTrials.ai's efforts to bridge communication gaps regarding Expanded Access Programs can assist physicians in navigating administrative processes for patients who may qualify for such programs.
MyTrials.ai is designed to integrate with various components of the clinical trial ecosystem. It can connect with EMR or health-data networks to surface trial-eligible patients to providers. The platform also offers direct API integration with CTMS/EDC stacks for CROs.
Details
| Category | Drug Discovery & Research, Patient Engagement & Education |
| Pricing | Unknown — unknown |
| Deployment | Cloud-based |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
Unknown AI-estimated MyTrials.ai does not explicitly state FDA clearance. However, it adheres to 21 CFR Part 11, which relates to electronic records and electronic signatures for FDA-regulated industries. |
| Integrations | |
| EHR | Not specified |
| Specialties | Cardiology, Neurology, Oncology |
What the Web Says
MyTrials.ai is an AI-powered platform designed to connect patients with suitable clinical trials by pre-screening and matching them based on eligibility criteria. It aims to simplify the often-complex process of finding and understanding clinical trials for both patients and researchers, offering plain-language explanations and real-time dashboards for trial management. The platform emphasizes data security and compliance with regulations like HIPAA, PIPEDA, and GDPR.
Overall: PositiveStrengths
- Simplifies clinical trial search for patients and caregivers by using plain language and AI matching.
- Reduces time spent on manual outreach and increases enrollment efficiency for researchers and sponsors.
- Offers real-time dashboards with insights into referral volume, patient demographics, and engagement rates.
- Compliant with industry regulations such as HIPAA, PIPEDA, and GDPR.
- Provides free resources for patients, including a checklist for questions to ask trial teams and a consent form review sheet.
- Can be used for multi-site and international trials with region-based matching and localized pre-screening.
Limitations
- No specific negative reviews from physicians, healthcare IT, or tech reviewers were found for MyTrials.ai.
- Some general concerns about AI tools in healthcare include the potential for hidden or unexpected fees and difficult cancellation processes, as seen with similar platforms.
- The broader landscape of AI in healthcare sometimes faces skepticism regarding its ability to replace human judgment or provide comprehensive medical advice.
- General challenges with AI tools include a potential learning curve and limitations in flexibility.
Based on reviews from: Trustpilot, MyTrials.ai FAQ, MyTrials.ai Blog, MyTrials.ai About Us, MyTrials.ai For Patients, Capterra, G2, Reddit, Harvard Business School AI Institute, Facebook
Last updated: 2026-10-01
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate MyTrials.ai
Press & Coverage
The Daily Scan
Using AI to make life-saving clinical trials more accessible to patients - The Daily Scan
MyTrials.ai, co-founded by Dr. Zachary Laksman, secured a $100,000 investment from Providence Health Care Ventures (PHC Ventures) to revolutionize patient access to clinical trials through AI. This collaboration aims to accelerate MyTrials.ai's growth and impact, ultimately helping more patients find and access cutting-edge clinical trials.
2025-01
Constant Contact (BioLinks Newsletter)
BioLinks | Your Weekly Life Sciences Newsletter - Constant Contact
Providence Health Care Ventures is investing $100K in MyTrials.ai, a company founded by Dr. Zachary Laksman, an in-house entrepreneur and clinician with Providence Health Care, to revolutionize clinical trial recruitment. MyTrials.ai is at the forefront of revolutionizing clinical trial recruitment.
2025-01
MyTrials.ai Blog
Rare Disease Clinical Trials: Why They Matter More Than Ever - MyTrials.ai
This article discusses how AI-driven platforms like MyTrials.ai, patient advocacy, and global collaboration are transforming rare disease clinical trials, making them faster, more accessible, and more impactful. MyTrials.ai aims to ensure no patient struggles to find a clinical trial, especially when it could mean the difference between life and death.
2025-03
MyTrials.ai Blog
Understanding Expanded Access Programs - MyTrials.ai
MyTrials.ai is building a patient-centered ecosystem where clinical trials, expanded access, off-label treatments, and regulatory updates are all searchable, transparent, and actionable. The platform aims to help patients explore all options, including compassionate use, and bridge the communication gap between patients, physicians, and sponsors.
2025-04
MyTrials.ai Blog
The Globalization of Clinical Trials: How Research is Expanding Beyond Borders
This article explores how global clinical trials are transforming drug development and how MyTrials.ai helps patients and researchers access and manage international studies through AI-powered trial matching and accessibility tools. MyTrials.ai is paving the way for a more efficient, patient-centric approach to international clinical trials by combining AI, automation, and global connectivity.
2025-03
TrendFeedr
Clinical Trial Report | TrendFeedr
MyTrials.ai is highlighted as a top company in clinical trials, applying machine learning to predict enrollment bottlenecks and optimize site selection, which can reduce time-to-first-patient by up to 30 percent. The report emphasizes that clinical trials are evolving through digital and methodological innovations, including AI-enabled monitoring.
2025-09
Providence Health Care Ventures
New St. Paul's Hospital: Vancouver's Future of Healthcare Innovation - Providence Health Care Ventures
PHC Ventures invests in early-stage startups like MyTrials.ai, a Vancouver-based AI platform that helps people find and connect with clinical trials globally at no cost. MyTrials.ai was co-founded by Dr. Zachary Laksman, a cardiologist at St. Paul's, and biomedical engineers Omar Asaker and Tyler Connelly.
2025-12
PitchBook
MyTrials.ai 2026 Company Profile: Valuation, Funding & Investors | PitchBook
MyTrials.ai, founded in 2024 and headquartered in Vancouver, Canada, is a private company in the Other Healthcare Technology Systems industry. The company has raised $292K in funding from investors including Front Row Ventures and Providence Health.
2026
Videos
Product demos, reviews, and walkthroughs for MyTrials.ai.
Loading videos...
Frequently Asked Questions
MyTrials.ai employs robust encryption protocols, de-identification techniques, and strict access controls to protect patient data. We are fully compliant with HIPAA regulations and other relevant data privacy laws, ensuring all patient information is handled with the utmost confidentiality and security throughout the AI matching process.
While highly advanced, MyTrials.ai's AI may have limitations in interpreting highly nuanced or ambiguously documented patient data, or in identifying extremely rare trial criteria. We address this by incorporating physician oversight and a feedback loop, allowing for manual review and correction, continuously refining the AI's accuracy and expanding its understanding of complex medical profiles.
MyTrials.ai leverages advanced AI and machine learning to analyze vast datasets and patient profiles with unparalleled speed and precision, often identifying matches that might be missed by manual review or less sophisticated platforms. Our system offers real-time updates, personalized patient-physician dashboards, and aims to significantly reduce the time and resources spent on trial recruitment, ultimately accelerating research.
MyTrials.ai offers flexible pricing models tailored to the needs of both individual practitioners and larger healthcare organizations. We provide tiered subscriptions based on usage, features, and the scale of implementation, with options for pilot programs and enterprise-level solutions. Specific pricing details can be discussed with our sales team to best fit your practice's requirements.
Yes, MyTrials.ai is designed for seamless integration with most major EHR systems through secure APIs, minimizing disruption to your current workflows. The implementation process typically involves an initial assessment of your existing infrastructure, followed by a phased integration and thorough testing, with dedicated support provided throughout to ensure a smooth transition.
Suggest an Edit →
| Last Verified: 2026-09-30 | First Added: 2026-09-30